Close Menu

People with sickle cell disease are hopeful that the gene-editing tool CRISPR might be able to offer them relief, Technology Review reports.

"Patients are very intrigued by [CRISPR]. They think it sounds wonderful," Biree Andemariam, director of the New England Sickle Cell Institute at the University of Connecticut Health Center, tells Tech Review.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

AstraZeneca has released its coronavirus vaccine trial protocol, according to the New York Times.

Time magazine looks into how liquid biopsies are changing cancer care.

According to the Guardian, more than 150 countries have signed on to a global SARS-CoV-2 vaccine plan.

In PNAS this week: similar muscle protein patterns across hypertrophic cardiomyopathy phenotypes, analysis of gene expression and brain anatomy in major depression, and more.